Search - tctmd.com

Displaying 621 - 640 of 948

Sort: Relevancy | Date

Presentation TCT 2019

Transcatheter Aortic Valve Replacement in Complex Anatomy

Presenter: Futoshi Yamanaka, MD

September 25, 2019

Session II: RCIS Advanced Session — Interventional Hemodynamics of the Aortic Valve - Transcatheter Aortic Valve Replacement and How I Treated My Patient

Presentation TCT 2019

Transcatheter Aortic Valve Replacement and How I Treated My Patient

Presenter: Paul Mahoney

September 25, 2019

Presentation TVT 2019

Functional Status After Transcatheter and Surgical Aortic Valve Replacement: A Two-Year Analysis From the SURTAVI Trial

Presenter: Mark Tuttle

June 15, 2019

Presentation TVT 2019

Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial

Presenter: Philippe Pibarot

June 14, 2019

Presentation TVT 2019

Hemodynamic Outcomes and Predictors of Prosthesis-Patient Mismatch After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients: Results from the Evolut Low-Risk Trial

Presenter: Mubashir Mumtaz

June 14, 2019

Presentation TVT 2019

Outcomes Following Transcarotid Versus Transpical/Transaortic Access for Transcatheter Aortic Valve Replacement: Results from the Transcatheter Valve Therapy (TVT) Registry

Presenter: Keith Allen

June 14, 2019

Presentation TVT 2019

Pacemaker Dependency at 90 Days After Transcatheter Aortic Valve Replacement

Presenter: Mohanad Hamandi

June 14, 2019

Presentation TVT 2019

Incidence of the Pseudoaneurysm After Transcatheter Aortic Valve Replacement: A Single-Center Experience

Presenter: Alexis Okoh

June 14, 2019

Presentation TVT 2019

Machine Learning-Based Prediction of Pacemaker Implantation After Transcatheter Aortic Valve Replacement

Presenter: Anvi Raina

June 14, 2019

Presentation TVT 2019

Predictors of Late (≥ 30 Days) Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement

Presenter: Alexis Okoh

June 14, 2019

Presentation TVT 2019

Impact of Pre-Existing Atrial Fibrillation on Clinical Outcomes in Patients Who Underwent Balloon-Expandable Transcatheter Aortic Valve Replacement

Presenter: Hyungdon Kook

June 14, 2019

Presentation TVT 2019

Ferumoxytol Enhanced MRA for Transcatheter Aortic Valve Replacement Planning in Patients With Chronic Kidney Disease

Presenter: Anjali Sharma

June 14, 2019

Presentation TVT 2019

The Utility of Transcatheter Aortic Valve Replacement in Very Low-Gradient Severe Aortic Stenosis

Presenter: Giorgio Medranda

June 14, 2019

Presentation TVT 2019

Comparison of Procedural and Clinical Outcomes Between the Sapien XT and the Sapien 3 Valves in Transcatheter Aortic Valve Replacement

Presenter: Hyungdon Kook

June 14, 2019

Presentation TVT 2019

Valve Performance and Durability After Transcatheter Versus Surgical Aortic Valve Replacement — A Meta-Analysis of Randomized Controlled Trials

Presenter: Ankur Sethi

June 14, 2019

Presentation TVT 2019

Impact of Frailty Score on Quality of Life After Transcatheter Aortic Valve Replacement in Nonagenarians

Presenter: Ramez Morcos

June 14, 2019

Presentation TVT 2019

Frequency and Consequences of Adverse Events After Transcatheter or Surgical Aortic Valve Replacement in Medicare Beneficiaries

Presenter: Carlos Sanchez

June 14, 2019

Presentation TVT 2019

Diastolic Dysfunction and Clinical Outcomes in Non-Typical Aortic Stenosis Subtypes After Transcatheter Aortic Valve Replacement

Presenter: Rashad Belin

June 14, 2019

Presentation TVT 2019

Renin-Angiotensin-Aldosterone System Inhibitors Are Associated With Reno-Protective Effects in Aging Patients Undergoing Transcatheter Aortic Valve Replacement

Presenter: Alexis Okoh

June 14, 2019

Presentation TVT 2019

Utilizing a Protocol-Driven vs. a Guideline-Driven Approach for Management of Conduction Abnormalities After Transcatheter Aortic Valve Replacement

Presenter: Chad Kliger

June 14, 2019

Advertisement

Transcatheter Aortic Valve Replacement in Complex Anatomy

Transcatheter Aortic Valve Replacement and How I Treated My Patient

Functional Status After Transcatheter and Surgical Aortic Valve Replacement: A Two-Year Analysis From the SURTAVI Trial

Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial

Hemodynamic Outcomes and Predictors of Prosthesis-Patient Mismatch After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients: Results from the Evolut Low-Risk Trial

Outcomes Following Transcarotid Versus Transpical/Transaortic Access for Transcatheter Aortic Valve Replacement: Results from the Transcatheter Valve Therapy (TVT) Registry

Pacemaker Dependency at 90 Days After Transcatheter Aortic Valve Replacement

Incidence of the Pseudoaneurysm After Transcatheter Aortic Valve Replacement: A Single-Center Experience

Machine Learning-Based Prediction of Pacemaker Implantation After Transcatheter Aortic Valve Replacement

Predictors of Late (≥ 30 Days) Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement

Impact of Pre-Existing Atrial Fibrillation on Clinical Outcomes in Patients Who Underwent Balloon-Expandable Transcatheter Aortic Valve Replacement

Ferumoxytol Enhanced MRA for Transcatheter Aortic Valve Replacement Planning in Patients With Chronic Kidney Disease

The Utility of Transcatheter Aortic Valve Replacement in Very Low-Gradient Severe Aortic Stenosis

Comparison of Procedural and Clinical Outcomes Between the Sapien XT and the Sapien 3 Valves in Transcatheter Aortic Valve Replacement

Valve Performance and Durability After Transcatheter Versus Surgical Aortic Valve Replacement — A Meta-Analysis of Randomized Controlled Trials

Impact of Frailty Score on Quality of Life After Transcatheter Aortic Valve Replacement in Nonagenarians

Frequency and Consequences of Adverse Events After Transcatheter or Surgical Aortic Valve Replacement in Medicare Beneficiaries

Diastolic Dysfunction and Clinical Outcomes in Non-Typical Aortic Stenosis Subtypes After Transcatheter Aortic Valve Replacement

Renin-Angiotensin-Aldosterone System Inhibitors Are Associated With Reno-Protective Effects in Aging Patients Undergoing Transcatheter Aortic Valve Replacement

Utilizing a Protocol-Driven vs. a Guideline-Driven Approach for Management of Conduction Abnormalities After Transcatheter Aortic Valve Replacement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content